Kristensen SL, Rorth R, Jhund PS, Docherty KF, Sattar N, Preiss D, et al
C.OkekeE
Baseline IGF-1 levels before starting treatment are the single strongest predictor of how dramatic the before and after difference will be
Key Benefits of Tesamorelin Targeted visceral fat reduction in the abdominal cavity Improved metabolic markers, including triglyceride levels and insulin sensitivity Enhanced cognition, sleep quality, and energy in individuals with GH deficiency Convenient once-daily injection Because visceral fat is linked to cardiovascular disease, insulin resistance, and type 2 diabetes, Tesamorelin plays a pivotal role in reducing cardiometabolic risk in affected populations
This is not a direct comparison since populations differ, but it underscores that PT-141 might not replace PDE5is as the first choice for everyone
While not common, some people report joint sensitivity during rapid weight loss